Implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy: an updated systematic review and meta-analysis of outcomes and complications

BACKGROUND: Since the introduction of the implantable cardioverter-defibrillator (ICD) in patients with hypertrophic cardiomyopathy (HCM), the incidence of sudden cardiac death (SCD) has been significantly reduced. Given its widespread use, it is important to identify the outcomes associated with IC...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Ann Cardiothorac Surg
Main Authors: Wang, Nelson, Xie, Ashleigh, Tjahjono, Richard, Tian, David H., Phan, Steven, Yan, Tristan D., Bajona, Pietro, Phan, Kevin
Formato: Artigo
Idioma:Inglês
Publicado: AME Publishing Company 2017
Assuntos:
Systematic Review
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5602202/
https://ncbi.nlm.nih.gov/pubmed/28944170
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/acs.2017.07.05
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares